<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04909151</url>
  </required_header>
  <id_info>
    <org_study_id>2-1040781-A-N-012021050HR</org_study_id>
    <nct_id>NCT04909151</nct_id>
  </id_info>
  <brief_title>The Effect of Robot-assisted Gait Training on Gait Ability in Children With Cerebral Palsy Through Changing Gait Speed</brief_title>
  <official_title>The Effect of Robot-assisted Gait Training on Gait Ability in Children With Cerebral Palsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sahmyook University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sahmyook University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Robot-assisted gait training (RAGT) improves the gait ability of children with cerebral&#xD;
      palsy, and can provide treatment plans and guidelines through changed records of various gait&#xD;
      variables. There is a lack of concrete explanations or arguments for gait speed, weight&#xD;
      support ratio, support force, joint angle, etc. that can be set in the RAGT system, and&#xD;
      intervention intensity for an appropriate intervention program has not been presented.&#xD;
      Therefore, in this study, we would like to suggest clinically effective interventions for&#xD;
      children with cerebral palsy in the second stage of the gross motor function classification&#xD;
      system (GMFCS) by identifying gait variables according to differences in gait speed during&#xD;
      RAGT.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 18, 2021</start_date>
  <completion_date type="Anticipated">November 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gait ability</measure>
    <time_frame>Change from baseline gait ability at 6 weeks</time_frame>
    <description>Gait ability is evaluated using the Zebris FDM-Treadmill. When the participants walks on the treadmill, the foot pressure is recorded at a rate of 120 Hz. The input pressure signal is displayed as a 2D/3D graph including the center of pressure while standing or walking, and the spatiotemporal measurements are displayed.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">39</enrollment>
  <condition>Cerebral Palsy</condition>
  <condition>Gait Disorders, Neurologic</condition>
  <condition>Bilateral Spastic Cerebral Palsy</condition>
  <arm_group>
    <arm_group_label>Robot-assisted gait training with walking speed of 0.5km/h</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Robot-assisted gait training with walking speed of 0.8km/h</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Robot-assisted gait training with walking speed of 1.1km/h</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Robot-assisted gait training (walking speed: 0.5km/h)</intervention_name>
    <description>Robot-assisted gait training RAGT, WALKBOT-G, is a walking training equipment that can reproduce natural motions by adjusting the leg length and adjusting the motion with the actuator of the ankle joint.</description>
    <arm_group_label>Robot-assisted gait training with walking speed of 0.5km/h</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Robot-assisted gait training (walking speed: 0.8km/h)</intervention_name>
    <description>Robot-assisted gait training RAGT, WALKBOT-G, is a walking training equipment that can reproduce natural motions by adjusting the leg length and adjusting the motion with the actuator of the ankle joint.</description>
    <arm_group_label>Robot-assisted gait training with walking speed of 0.8km/h</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Robot-assisted gait training (walking speed: 1.1km/h)</intervention_name>
    <description>Robot-assisted gait training RAGT, WALKBOT-G, is a walking training equipment that can reproduce natural motions by adjusting the leg length and adjusting the motion with the actuator of the ankle joint.</description>
    <arm_group_label>Robot-assisted gait training with walking speed of 1.1km/h</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients 4-12 years old diagnosed with cerebral palsy&#xD;
&#xD;
          -  Children who have not received botulinum toxin treatment or surgery within 3 months&#xD;
&#xD;
          -  Children in stage 2 of the gross motor function system&#xD;
&#xD;
          -  Children who can express pain, fear, or discomfort on their own&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe lower extremity contracture and fracture&#xD;
&#xD;
          -  Bone instability&#xD;
&#xD;
          -  Osteoporosis&#xD;
&#xD;
          -  Severe bones grow disproportionately&#xD;
&#xD;
          -  Unhealed skin lesions on the lower extremities (thromboembolic disease)&#xD;
&#xD;
          -  Thromboembolic disease&#xD;
&#xD;
          -  Cardiovascular instability&#xD;
&#xD;
          -  Mild scoliosis with a Cobb's angle of more than 20 degrees&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sun-Geon Park, Ph.D candidate</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Wells Neuro Pain Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sun-Geon Park, Ph.D candidate</last_name>
    <phone>+82-10-6204-8377</phone>
    <email>spring1056@naver.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Pajucity convalescent Hospital</name>
      <address>
        <city>Paju</city>
        <zip>10915</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sun-Geon Park</last_name>
      <phone>+82-31-942-7500</phone>
      <email>spring1056@naver.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 26, 2021</study_first_submitted>
  <study_first_submitted_qc>May 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2021</study_first_posted>
  <last_update_submitted>June 18, 2021</last_update_submitted>
  <last_update_submitted_qc>June 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sahmyook University</investigator_affiliation>
    <investigator_full_name>Hyun-Joong Kim</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paralysis</mesh_term>
    <mesh_term>Cerebral Palsy</mesh_term>
    <mesh_term>Nervous System Diseases</mesh_term>
    <mesh_term>Gait Disorders, Neurologic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methamphetamine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>I plan to decide after the study is over.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

